Fig. 8From: Efficacy and safety of gut microbiota-based therapies in autoimmune and rheumatic diseases: a systematic review and meta-analysis of 80 randomized controlled trialsOutcomes of ulcerative colitis (A Endoscopy Score; B Ineffective rate; C Disease activity; D Relapse rate; E ESR; F: CRP)Back to article page